Real-time enrollment status for this alk-positive nsclc clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:20 AM UTC
| NCT Number | NCT07491497 |
| Recruiting Status | Recruiting |
| Condition | ALK-positive NSCLC |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 12 sites in the US |
| Sponsor | TRIANA Biomedicines, Inc. |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of August 27, 2026: Clinical trial NCT07491497 is currently recruiting participants. This phase1 study for alk-positive nsclc is actively seeking new participants at 12 locations across the United States. The study is sponsored by TRIANA Biomedicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07491497 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07491497 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.